Results 141 to 150 of about 149,288 (230)
A point mutation in IAA34 confers resistance to the auxin herbicide 2,4-D in Sisymbrium orientale. [PDF]
Qi Y, Krishnan M, Tucker M, Preston C.
europepmc +1 more source
The Response of Iranian Melon (Cucumis melo L.) Accessions to 2,4-D Drift. [PDF]
Zangoueinejad R +3 more
europepmc +1 more source
Abstract This technical note describes a knotless trans‐tendon proximal‐pulley repair with distal suture‐bridge fixation and bioinductive collagen patch augmentation for high‐grade partial gluteus medius and minimus tears. The technique preserves intact tendon fibers, restores broad footprint compression, and supports biologic healing through a ...
Maria Agustina Olarán +6 more
wiley +1 more source
Production of Indole-3-Acetic Acid and Degradation of 2,4-D by Yeasts Isolated from Pollinating Insects. [PDF]
Oliveira CG +8 more
europepmc +1 more source
Effects on Pseudomonas plecoglossicida 2,4-D and Humic Substances on the Growth, Pigment Indices and Concentration of Hormones in Wheat Seedlings Grown under Water Deficit. [PDF]
Feoktistova A +4 more
europepmc +1 more source
Abstract Patellar dislocation is a frequent emergency presentation. First‐time dislocations are associated with medial patellofemoral ligament injury in up to 94.7% of cases. Although many reduce spontaneously, reduction under anesthesia may be required.
Hesham Ahmed Abdul Galil +3 more
wiley +1 more source
Regulators use expedited approval pathways to speed market approval and patient access to promising new drugs. However, there is uncertainty about whether these pathways are successful in approving drugs with significant therapeutic advantages. This systematic review aims to examine the safety, effectiveness and cost‐effectiveness of drugs approved via
Ashleigh Hooimeyer +4 more
wiley +1 more source
Different nontarget-site mechanisms underlie resistance to dicamba and 2,4-D in an Amaranthus tuberculatus population. [PDF]
Werle IS +5 more
europepmc +1 more source
Aims GLP‐1 medicines provide substantial cardio‐renal benefits for type 2 diabetes (T2D) and are increasingly used for weight loss. Most high‐income countries subsidize access for T2D with restrictions; use outside of these restrictions occurs through private prescriptions. Despite strong consumer demand, the extent of private access to GLP‐1 medicines
Michael O. Falster +10 more
wiley +1 more source

